The global Micafungin Sodium for Injection market was valued at 347.19 Million USD in 2020 and will grow with a CAGR of 2.29% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.In 2013, Japan was the largest consumption place, with a consumption market share nearly 35.40%. In 2017, North America is the largest consumption place with the consumption market share of 28.98%.
By Market Verdors:
Astellas
By Types:
50 mg Single-use Vial
100 mg Single-use Vial
By Applications:
Candidemia
Respiratory Mycosis
Gastrointestinal Mycosis
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Micafungin Sodium for Injection Revenue
1.4 Market Analysis by Type
1.4.1 Global Micafungin Sodium for Injection Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 50 mg Single-use Vial
1.4.3 100 mg Single-use Vial
1.5 Market by Application
1.5.1 Global Micafungin Sodium for Injection Market Share by Application: 2022-2027
1.5.2 Candidemia
1.5.3 Respiratory Mycosis
1.5.4 Gastrointestinal Mycosis
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Micafungin Sodium for Injection Market
1.8.1 Global Micafungin Sodium for Injection Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Micafungin Sodium for Injection Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Micafungin Sodium for Injection Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Micafungin Sodium for Injection Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Micafungin Sodium for Injection Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Micafungin Sodium for Injection Sales Volume Market Share by Region (2016-2021)
3.2 Global Micafungin Sodium for Injection Sales Revenue Market Share by Region (2016-2021)
3.3 North America Micafungin Sodium for Injection Sales Volume
3.3.1 North America Micafungin Sodium for Injection Sales Volume Growth Rate (2016-2021)
3.3.2 North America Micafungin Sodium for Injection Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Micafungin Sodium for Injection Sales Volume
3.4.1 East Asia Micafungin Sodium for Injection Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Micafungin Sodium for Injection Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Micafungin Sodium for Injection Sales Volume (2016-2021)
3.5.1 Europe Micafungin Sodium for Injection Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Micafungin Sodium for Injection Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Micafungin Sodium for Injection Sales Volume (2016-2021)
3.6.1 South Asia Micafungin Sodium for Injection Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Micafungin Sodium for Injection Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Micafungin Sodium for Injection Sales Volume (2016-2021)
3.7.1 Southeast Asia Micafungin Sodium for Injection Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Micafungin Sodium for Injection Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Micafungin Sodium for Injection Sales Volume (2016-2021)
3.8.1 Middle East Micafungin Sodium for Injection Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Micafungin Sodium for Injection Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Micafungin Sodium for Injection Sales Volume (2016-2021)
3.9.1 Africa Micafungin Sodium for Injection Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Micafungin Sodium for Injection Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Micafungin Sodium for Injection Sales Volume (2016-2021)
3.10.1 Oceania Micafungin Sodium for Injection Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Micafungin Sodium for Injection Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Micafungin Sodium for Injection Sales Volume (2016-2021)
3.11.1 South America Micafungin Sodium for Injection Sales Volume Growth Rate (2016-2021)
3.11.2 South America Micafungin Sodium for Injection Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Micafungin Sodium for Injection Sales Volume (2016-2021)
3.12.1 Rest of the World Micafungin Sodium for Injection Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Micafungin Sodium for Injection Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Micafungin Sodium for Injection Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Micafungin Sodium for Injection Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Micafungin Sodium for Injection Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Micafungin Sodium for Injection Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Micafungin Sodium for Injection Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Micafungin Sodium for Injection Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Micafungin Sodium for Injection Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Micafungin Sodium for Injection Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Micafungin Sodium for Injection Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Micafungin Sodium for Injection Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Micafungin Sodium for Injection Sales Volume Market Share by Type (2016-2021)
14.2 Global Micafungin Sodium for Injection Sales Revenue Market Share by Type (2016-2021)
14.3 Global Micafungin Sodium for Injection Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Micafungin Sodium for Injection Consumption Volume by Application (2016-2021)
15.2 Global Micafungin Sodium for Injection Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Micafungin Sodium for Injection Business
16.1 Astellas
16.1.1 Astellas Company Profile
16.1.2 Astellas Micafungin Sodium for Injection Product Specification
16.1.3 Astellas Micafungin Sodium for Injection Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Micafungin Sodium for Injection Manufacturing Cost Analysis
17.1 Micafungin Sodium for Injection Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Micafungin Sodium for Injection
17.4 Micafungin Sodium for Injection Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Micafungin Sodium for Injection Distributors List
18.3 Micafungin Sodium for Injection Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Micafungin Sodium for Injection (2022-2027)
20.2 Global Forecasted Revenue of Micafungin Sodium for Injection (2022-2027)
20.3 Global Forecasted Price of Micafungin Sodium for Injection (2016-2027)
20.4 Global Forecasted Production of Micafungin Sodium for Injection by Region (2022-2027)
20.4.1 North America Micafungin Sodium for Injection Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Micafungin Sodium for Injection Production, Revenue Forecast (2022-2027)
20.4.3 Europe Micafungin Sodium for Injection Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Micafungin Sodium for Injection Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Micafungin Sodium for Injection Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Micafungin Sodium for Injection Production, Revenue Forecast (2022-2027)
20.4.7 Africa Micafungin Sodium for Injection Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Micafungin Sodium for Injection Production, Revenue Forecast (2022-2027)
20.4.9 South America Micafungin Sodium for Injection Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Micafungin Sodium for Injection Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Micafungin Sodium for Injection by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Micafungin Sodium for Injection by Country
21.2 East Asia Market Forecasted Consumption of Micafungin Sodium for Injection by Country
21.3 Europe Market Forecasted Consumption of Micafungin Sodium for Injection by Countriy
21.4 South Asia Forecasted Consumption of Micafungin Sodium for Injection by Country
21.5 Southeast Asia Forecasted Consumption of Micafungin Sodium for Injection by Country
21.6 Middle East Forecasted Consumption of Micafungin Sodium for Injection by Country
21.7 Africa Forecasted Consumption of Micafungin Sodium for Injection by Country
21.8 Oceania Forecasted Consumption of Micafungin Sodium for Injection by Country
21.9 South America Forecasted Consumption of Micafungin Sodium for Injection by Country
21.10 Rest of the world Forecasted Consumption of Micafungin Sodium for Injection by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer